Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Immunome (IMNM) Accumulated Depreciation & Amortization (2023 - 2024)

Historic Accumulated Depreciation & Amortization for Immunome (IMNM) over the last 2 years, with Q4 2024 value amounting to $4.7 million.

  • Immunome's Accumulated Depreciation & Amortization rose 2152.0% to $4.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.7 million, marking a year-over-year increase of 2152.0%. This contributed to the annual value of $4.7 million for FY2024, which is 2152.0% up from last year.
  • According to the latest figures from Q4 2024, Immunome's Accumulated Depreciation & Amortization is $4.7 million, which was up 2152.0% from $3.9 million recorded in Q4 2023.
  • Immunome's 5-year Accumulated Depreciation & Amortization high stood at $4.7 million for Q4 2024, and its period low was $3.9 million during Q4 2023.